1. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
- Author
-
Araujo Ribeiro M, Alastruey-Izquierdo A, Gomez-Lopez A, Rodriguez-Tudela JL, and Cuenca-Estrella M
- Subjects
- Amphotericin B pharmacology, Antifungal Agents pharmacology, Brazil epidemiology, Cross Infection epidemiology, Dermatomycoses microbiology, Echinocandins pharmacology, Female, Flucytosine pharmacology, Fungemia microbiology, Hospitals, University statistics & numerical data, Humans, Mycological Typing Techniques methods, Mycoses epidemiology, Onychomycosis microbiology, Opportunistic Infections epidemiology, Opportunistic Infections microbiology, Organ Specificity, Triazoles pharmacology, Trichosporon classification, Trichosporon drug effects, Urine microbiology, Vaginitis microbiology, Cross Infection microbiology, Drug Resistance, Fungal, Mycoses microbiology, Trichosporon isolation & purification
- Abstract
In this study the molecular identification and susceptibility profile of 21 clinical isolates, from a Brazilian hospital, belongs to six different species of Trichosporon were described. Trichosporon asahii was the predominant species and corresponded to 43% of isolates. Eighty three percent of the strains isolated from deep sites were identified as T. asahii, while only 17% belong to a non-T. asahii species (Trichosporon inkin). In general, the MICs were high and independent of the species of Trichosporon as well as the clinical origin of strain. Amphotericin B and fluconazole were less effective against Trichosporon spp. and high MIC values of voriconazole, posaconazole and ravuconazole were observed. Fifty-six percent (5/9) of T. asahii strains were isolated from deep sites, whereas 8% (1/12) of non-T. asahii species were isolated from those sites. A total of 89% of T. asahii isolates exhibited resistance to amphotericin B in vitro.
- Published
- 2008